NT Group (n=18) Control Group (n=18)
p1
Mean±SD Mean±SD Mean±SD
VAS
Pre-treatment 7.88±1.18 7.88±1.18 7.61±1.24 0.481*
First month after treatment 1.66±0.90 1.66±0.90 4.22±1.47 <0.001*
12th month after treatment 1.66±1.78 1.66±1.78 3.83±2.09 0.002*
p2<0.001** p2<0.001** p2<0.001**
DHI
Pre-treatment 40.55±13.11 40.55±13.11 26.83±13.16 0.004***
First month after treatment 8.94±5.81 8.94±5.81 16.61±10.27 0.009***
12th month after treatment 8.83±11.49 8.83±11.49 12.66±7.89 0.252*
p2<0.001**** p2<0.001**** p2<0.001****
* Mann Whitney U test ** Wilcoxon signed rank test *** t test **** t test in dependent groups NT: Neural therapy; VAS: Visual Analog Scale; DHI: Duruöz Hand Index * Mann Whitney U test ** Wilcoxon signed rank test *** t test **** t test in dependent groups NT: Neural therapy; VAS: Visual Analog Scale; DHI: Duruöz Hand Index * Mann Whitney U test ** Wilcoxon signed rank test *** t test **** t test in dependent groups NT: Neural therapy; VAS: Visual Analog Scale; DHI: Duruöz Hand Index * Mann Whitney U test ** Wilcoxon signed rank test *** t test **** t test in dependent groups NT: Neural therapy; VAS: Visual Analog Scale; DHI: Duruöz Hand Index * Mann Whitney U test ** Wilcoxon signed rank test *** t test **** t test in dependent groups NT: Neural therapy; VAS: Visual Analog Scale; DHI: Duruöz Hand Index